Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna(Universitat de Barcelona), Diego Muñoz‐Torrero(Institute for Research in Biomedicine), Nicolas Coquelle(Centre National de la Recherche Scientifique), Florian Nachon(Institut de Médecine Tropicale du Service de Santé des Armées), Xavier Brazzolotto(Institut de Médecine Tropicale du Service de Santé des Armées), Israel Silman(Weizmann Institute of Science), Mattia Ricchini(Universitat de Barcelona), Jacques‐Philippe Colletier(Centre National de la Recherche Scientifique), Mégane Pons(Centre National de la Recherche Scientifique), Monika Cieslikiewicz‐Bouet(Centre National de la Recherche Scientifique), Belén Pérez(Universitat Autònoma de Barcelona), Miren Ettcheto(Universitat de Barcelona), Luciano Saso(Sapienza University of Rome), Marisa Rendina(Universitat de Barcelona), Carolina A. Oliva(Pontificia Universidad Católica de Chile), Angela De Simone(University of Turin), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Vincenza Andrisano(University of Bologna), Pierre‐Yves Renard(Centre National de la Recherche Scientifique), Ludovic Jean(Centre National de la Recherche Scientifique), Manuela Bartolini(University of Bologna), Omidreza Firuzi(Shiraz University of Medical Sciences), María L. García(Biomedical Research Networking Center on Neurodegenerative Diseases), Elena Sánchez‐López(Centro de Investigación Biomédica en Red), Nibaldo C. Inestrosa(Pontificia Universidad Católica de Chile), Pedro Cisternas(University of Concepción)
Cited by 94
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
|Journal of Biological Chemistry|2002|575